X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA CADILA HEALTHCARE ALEMBIC PHARMA/
CADILA HEALTHCARE
 
P/E (TTM) x 26.5 35.8 74.1% View Chart
P/BV x 6.1 9.2 65.7% View Chart
Dividend Yield % 0.8 0.7 117.2%  

Financials

 ALEMBIC PHARMA   CADILA HEALTHCARE
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
CADILA HEALTHCARE
Mar-16
ALEMBIC PHARMA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs792454 174.2%   
Low Rs443305 145.5%   
Sales per share (Unadj.) Rs167.096.1 173.8%  
Earnings per share (Unadj.) Rs38.214.9 256.6%  
Cash flow per share (Unadj.) Rs42.017.8 235.6%  
Dividends per share (Unadj.) Rs4.003.20 125.0%  
Dividend yield (eoy) %0.60.8 76.8%  
Book value per share (Unadj.) Rs84.952.3 162.4%  
Shares outstanding (eoy) m188.521,023.74 18.4%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x3.73.9 93.6%   
Avg P/E ratio x16.225.5 63.4%  
P/CF ratio (eoy) x14.721.3 69.1%  
Price / Book Value ratio x7.37.3 100.2%  
Dividend payout %10.521.5 48.7%   
Avg Mkt Cap Rs m116,383388,458 30.0%   
No. of employees `000NA15.4 0.0%   
Total wages/salary Rs m4,21413,317 31.6%   
Avg. sales/employee Rs ThNM6,371.1-  
Avg. wages/employee Rs ThNM862.4-  
Avg. net profit/employee Rs ThNM986.1-  
INCOME DATA
Net Sales Rs m31,48798,376 32.0%  
Other income Rs m55941 5.9%   
Total revenues Rs m31,54299,317 31.8%   
Gross profit Rs m10,06023,829 42.2%  
Depreciation Rs m7223,022 23.9%   
Interest Rs m37486 7.6%   
Profit before tax Rs m9,35621,262 44.0%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m-25 -30.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m2,1605,716 37.8%   
Profit after tax Rs m7,19415,226 47.3%  
Gross profit margin %31.924.2 131.9%  
Effective tax rate %23.126.9 85.9%   
Net profit margin %22.815.5 147.6%  
BALANCE SHEET DATA
Current assets Rs m15,06644,376 33.9%   
Current liabilities Rs m7,67434,071 22.5%   
Net working cap to sales %23.510.5 224.1%  
Current ratio x2.01.3 150.7%  
Inventory Days Days6754 124.3%  
Debtors Days Days4162 65.2%  
Net fixed assets Rs m8,23747,896 17.2%   
Share capital Rs m3771,024 36.8%   
"Free" reserves Rs m15,41648,746 31.6%   
Net worth Rs m16,00553,519 29.9%   
Long term debt Rs m08,964 0.0%   
Total assets Rs m24,594100,163 24.6%  
Interest coverage x255.244.7 570.4%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.31.0 130.4%   
Return on assets %29.415.7 187.4%  
Return on equity %44.928.4 158.0%  
Return on capital %58.734.3 171.1%  
Exports to sales %55.745.3 123.1%   
Imports to sales %10.45.9 175.7%   
Exports (fob) Rs m17,55144,537 39.4%   
Imports (cif) Rs m3,2835,838 56.2%   
Fx inflow Rs m17,81144,881 39.7%   
Fx outflow Rs m5,3189,069 58.6%   
Net fx Rs m12,49335,812 34.9%   
CASH FLOW
From Operations Rs m9,30419,938 46.7%  
From Investments Rs m-3,105-9,039 34.3%  
From Financial Activity Rs m-1,959-9,527 20.6%  
Net Cashflow Rs m4,2401,372 309.0%  

Share Holding

Indian Promoters % 74.1 74.8 99.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 8.3 34.9%  
FIIs % 9.1 5.9 154.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 11.0 126.4%  
Shareholders   49,328 44,069 111.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS